Abstract
Adrenaline and related substances were discussed in the 1924 edition of Heffter’s Handbook by Paul Trendelenburg. On 164 pages he described what was then known not only of adrenaline and its closest relatives but also of the sympathomimetic compounds such as tyramine and ephedrine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahlquist, R.P.: A study of the adrenotropic receptors. Amer. J. Physiol. 153, 586–600 (1948).
Armstrong, M.D., Mcmillan, A., Shaw, K.F.: 3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine. Biochim. biophys. Acta (Amst.) 25, 422–423 (1957).
Axelrod, J.: O-Methylation of epinephrine and other catechols in vitro and in vivo. Science 126, 400–401 (1957).
Axelrod, J.: Purification and properties of phenylethanolamine-N-methyl transferase. J. biol. Chem. 237, 1657–1660 (1962).
Axelrod, J.: Enzymic oxidation of epinephrine to adrenochrome by the salivary gland. Biochim. biophys. Acta (Amst.) 85, 247–254 (1964).
Axelrod, J.: Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol. Rev. 18, 95–113 (1966).
Axelrod, J. Tomchik, R.: Enzymatic O-methylation of epinephrine and other catechols. J. biol. Chem. 233, 702–705 (1958).
Bacq, Z.M.: La pharmacologie du système nerveux autonome, et particulièrement du sympathique d’après la théorie neurohumorale. Ann. Physiol. Physiochim. biol. 10, 467–528 (1934).
Bacq, Z.M.: La transmission chimique des influx dans le système nerveux autonome. Ergebn. Physiol. 37, 82–185 (1935).
Bacq, Z.M.: The metabolism of adrenaline. Pharmacol. Rev. 1, 1–27 (1949).
Banks, P., Helle, K.: The release of protein from the stimulated adrenal medulla. Biochem. J. 97, 40C–41C (1965).
Bein, H.J.: The pharmacology of Rauwolfia. Pharmacol. Rev. 8, 435–483 (1956).
Belleau, B.: The mechanism of drug action at receptor surfaces. Part I. Introduction. A general interpretation of the adrenergic blocking activity of /Mialoalkylamines. Canad. J. Biochem. 36, 731–753 (1958).
Belleau, B.: Relationships between agonists, antagonists and receptor sites. In: Ciba Foundation Symposium on Adrenergic Mechanisms, pp. 223–245. Ed. by J.R. Vane, G.E.W. Wol-Stenholme and Maeve O’connor. London: Churchill 1960.
Belleau, B., Btjrba, J., Pindell, M., Reiffenstein, J.: Effect of deuterium substitution in sympa-thomimetic amines on adrenergic responses. Science 133, 102–104 (1961).
Belleau, B., Fang, M., Burba, J., Moran, J.: The absolute optical specificity of monoamine oxidase. J. Amer. chem. Soc. 82, 5752–5754 (1960).
Bergeret, B., Blaschko, H., Hawes, R.: Occurrence of an amine oxidase in horse serum. Nature (Lond.) 180, 1127–1128 (1957).
Bertler, A., Rosengren, E.: Occurrence and distribution of dopamine in brain and other tissues. Experientia (Basel) 15, 10–11 (1959).
Birkmayer, W., Hornykiewicz, O.: Der L-3,4-Dioxyphenylalanin (=DOPA)-Effekt bei der Parkinson-Akinese. Wien. klin. Wschr. 73, 787–788 (1961).
Blaschko, H.: The specific action of 1-dopa decarboxylase. J. Physiol. (Lond.) 96, 50P–51P (1939).
Blaschko, H.: The activity of 1(-)-dopa decarboxylase. J. Physiol. (Lond.) 101, 337–349 (1942).
Blaschko, H.: Substrate specificity of amino-acid decarboxylases. Biochim. biophys. Acta (Amst.) 4, 130–137 (1950).
Blaschko, H.: Amine oxidase and amine metabolism. Pharmacol. Rev. 4, 415–458 (1952).
Blaschko, H.: Metabolism of epinephrine and norepinephrine. Pharmacol. Rev. 6, 23–28 (1954).
Blaschko, H.: Metabolism and storage of biogenic amines. Experientia (Basel) 13, 9–12 (1957a).
Blaschko, H.: Formation of catecholamines in the animal body. Brit. med. Bull. 13, 162–165 (1957b).
Blaschko, H.: The development of current concepts of catecholamine formation. Pharmacol. Rev. 11, 307–316 (1959).
Blaschko, H.: Chairman’s Opening Remarks. In: Ciba Foundation Symposium on Adrenergic Mechanisms, pp. 473–480. Ed. by J.R. Vane, G.E.W. Wolstenholme and Maeve O’connor. London: Churchill 1960.
Blaschko, H.: The amine oxidases of mammalian blood plasma. Advanc. comp. Physiol. Biochem. 1, 67–116 (1962).
Blaschko, H.: Buffoni, F.: Pyridoxal phosphate as a constituent of the histaminase (benzylamine oxidase) of pig plasma. Proc. roy. Soc. B. 163, 45–60 (1965).
Blaschko, H.: Weissman, N., Carnes, W.H., Coulson, W.F.: The amine oxidase of pig plasma in copper deficiency. Biochem. J. 96, 4C–5C (1965).
Blaschko, H., Chrusciel, T.L.: The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice. J. Physiol. (Lond.) 151, 272–284 (1960).
Blaschko, H., Comline, R.S., Schneider, F.H., Silver, M., Smith, A.D.: Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature (Lond.) 215, 58–59 (1967).
Blaschko, H., Hagen, J.M., Hagen, P.: Mitochondrial enzymes and chromaffin granules. J. Physiol. (Lond.) 139, 316–322 (1957).
Blaschko, H., Levine, W. G.: Observations on phenolases. Neuro-Psychopharmacology, 2,435–439. Ed. by E. ROTHLIN. Amsterdam: Elsevier 1961.
Blaschko, H., Richter, D., Schlossmann, H.: The inactivation of adrenaline. J. Physiol. (Lond.) 90, 1–19 (1937a).
Blaschko, H., Richter, D., Schlossmann, H.: The oxidation of adrenaline and other amines. Biochem. J. 31, 2187–2196 (1937b).
Blaschko, H., Smith, A.D.: Editors, Subcellular and macromolecular aspects of synaptic transmission. Phil. Trans, roy. Soc. B. 261, 273–437 (1971).
Blaschko, H., Welch, A.D.: Localization of adrenaline in cytoplasmic particles of the bovine adrenal medulla. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 219, 17–22 (1953).
Bloom, F.E., Iversen, L.L., Schmitt, F.O.: Editors, Macromolecules in synaptic function. Neurosciences Res. Prog. Bull. Vol. 8, No. 4, 325–455 (1970).
Buffoni, F., Blaschko, H.: Benzylamine oxidase and histaminase: purification and crystallization of an enzyme from pig plasma. Proc. roy. Soc. B. 161, 153–167 (1964).
Bülbring, E.: The methylation of noradrenaline by minced suprarenal tissue. Brit. J. Pharmacol. 4, 234–244 (1949).
Burn, J.H., Rand, M.J.: The action of sympathomimetic amines in animals treated with reserpine. J. Physiol. (Lond.) 144, 314–366 (1958).
Burn, J.H., Rand, M.J.: Sympathetic postganglionic mechanism. Nature (Lond.) 164, 163–165 (1959).
Cannon, W.B.: Die Notfallsfunktion des sympathico-adrenalen Systems. Ergebn. Physiol. 27, 380–406 (1928).
Cannon, W.B., Rosenblueth, A.: Autonomic neuro-effector systems. New York: Macmillan 1937.
Cannon, W.B., Ubidil, J.E.: Some effects on the denervated heart of stimulating the nerves of the liver. Amer. J. Physiol. 58, 353–364 (1921).
Carlsson, A., Lindqvist, M., Magnusson, T.: 3,4-Dihydroxyphenylalanine and 5-hydro-xytryptophan as reserpine antagonists. Nature (Lond.) 180, 1200 (1957).
Carlsson, A., Lindqvist, M., Magnusson, T., Rosengren, E., Bertler, A., Nilsson, J.: Eifect of reserpine on the metabolism of catecholamines. In: Psychotropic Drugs, pp. 363–372. Ed. by S. Garattini and V. Ghetti. Amsterdam: Elsevier 1957.
Carnes, W.H.: Copper and connective tissue metabolism. Int. Rev. Connective Tissue Res. 4, 197–232 (1968).
Clark, A.J.: General pharmacology. In: Handbuch der experimentellen Pharmakologie. Ed. by W. Heubner and J. Schüller. Ergänzungswerk, 4ter Band. Berlin: Julius Springer 1937.
Collins, C.G.S., Youdim, M.B.H.: Multiple forms of human brain monoamine oxidase. Biochem. J. 117, 43P (1970).
Cori, C.F.: Mammalian carbohydrate metabolism. Physiol. Rev. 11, 143–275 (1931).
Cotzias, G.C., Van Woert, M.H., Schiffer, I.M.: Aromatic amino acids and modification of Parkinsonism. New Engl. J. Med. 276, 374–379 (1967).
Dale, H.H.: Nomenclature of fibres in the autonomic system and their effects. J. Physiol. (Lond.) 80, 10P–11P (1933).
Dale, H.H.: General introductory address. In: Modes of drug action. A general discussion. Trans. Faraday Soc. 39, 319–322 (1943).
Dale, H.H.: Adventures in physiology. The Wellcome Trust: London 1965.
Della Corte, L., Perrino, I.: II ruolo delle aminossidasi plasmatiche nel metabolismo della dopamina. Farmaco, Ed. sci. 23, 204–209 (1968).
Demis, D.J., Blaschko, H., Welch, A.D.: The conversion of dihydroxyphenylalanine-2-C14 (dopa) to norepinephrine by bovine adrenal medullary homogenates. J. Pharmacol, exp. Ther. 113, 14–15 (1955).
Demis, D.J., Blaschko, H., Welch, A.D.: The conversion of dihydroxyphenylalanine-2-C14 (dopa) to norepinephrine by bovine adrenal medullary homogenate. J. Pharmacol, exp. Ther. 117, 208–212 (1956).
Douglas, W.W.: Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. Brit. J. Pharmacol. 34, 451–474 (1968).
Ehringer, R.H., Hornykiewicz, O.: Verteilung von Noradrenalin und Dopamin (3-Hydro-xytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wschr. 15, 1236–1239 (1960).
Elliott, T.R.: On the action of adrenalin. J. Physiol. (Lond.) 31, XX–XXI (1904).
Eränkö, O.: Distribution of fluorescing islets, adrenaline and noradrenaline in the adrenal medulla of the hamster. Acta endocr. (Kbh.) 18, 174–179 (1955).
Erwin, V.G., Hellerman, L.: Mitochondrial monoamine oxidase. I. Purification and characterization of the bovine kidnev enzyme. J. biol. Chem. 242, 4230–4238 (1967).
Von Euler, U.S., Hillarp, N.-A.: Evidence for the presence of noradrenaline in submicroscopic structures of adrenergic axons. Nature (Lond.) 177, 44–45 (1956).
Falck, B., Hillarp, N.-A., Thieme, G., Torp, A.: Fluorescence of catecholamines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10, 348–354 (1962).
Gaddum, J.H., Schild, H.: A sensitive physical test for adrenaline. J. Physiol. (Lond.) 80, 9P–10P (1934).
Gonzalez-Vegas, J.A., Wolstencroft, J.H.: Actions of 3,4-dimethoxyphenylethylamine in relation to the effects of catecholamines on brainstem neurones. Brit. J. Pharmacol. 41, 406P–407P (1971a).
Gonzalez-Vegas, J.A., Wolstencroft, J.H.: Antagonism of noradrenaline and dopamine inhibition of brain-stem neurones by bulbocapnine. J. Physiol. (Lond.) 214, 16P (1971b).
Goodall, McC.: Studies of adrenaline and noradrenaline in mammalian heart and supra-renals. Acta physiol. scand. 24, Suppl. 85, 7–51 (1951).
Goodall, McC., Kirshner, N.: Biosynthesis of adrenaline and noradrenaline in vitro. J. biol. Chem. 226, 213–221 (1957).
Goodall, McC., Kirshner, N.: Biosynthesis of epinephrine and norepinephrine by sympathetic nerves and ganglia. Circulation 17, 366–371 (1958).
Graefe, K.H., Trendelenburg, U.: The influence of intraneuronal inactivating mechanisms on the membrane-amine pump. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 266, 336–337 (1970).
Green, D.E., Richter, D.: Adrenaline and adrenochrome. Biochem. J. 31, 596–616 (1937).
Greer, C.M., Pinkston, J.O., Baxter, J.H., JR., Brannon, E.S.: Norepinephrine [β-(3,4-dihydroxyphenyl)-β-hydroxyethylamine] as a possible mediator in the sympathetic division of the autonomic nervous system. J. Pharmacol, exp. Ther. 62, 189–227 (1938).
Hägen, P.: Biosynthesis of norepinephrine from 3,4-dihydroxyphenylethylamine (dopamine). J. Pharmacol, exp. Ther. 116, 26 (1956).
Hägen, P., Welch, A.D.: The adrenal medulla and the biosynthesis of pressor amines. Recent Progr. Hormone Res. 12, 27–44 (1956).
Hare, M.L.C.: Tyramine oxidase. I. A new enzyme system in liver. Biochem. J. 22, 968–979 (1928).
Hegnauer, A., Cori, G.T.: The influence of epinephrine on chemical changes in isolated frog muscle, J. biol. Chem. 105, 691–703 (1934).
Hillarp, N.-Ä., Lagerstedt, S., Nilson, B.: The isolation of a granular fraction from the suprarenal medulla containing the sympathomimetic catecholamines. Acta physiol. scand. 28, 251–263 (1953).
Hirsch, J.G.: Spermine oxidase: an amine oxidase with specificity for spermine and sper-midine. J. exp. Med. 97, 345–355 (1953).
Holtz, P., Heise, R., Lüdtke, K.: Fermentativer Abbau von 1-Dioxyphenylalanin (dopa) durch Niere. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 191, 87–118 (1938).
Holtz, P., Heise, R., Lüdtke, K., Palm, D.: Brenzkatechinamine und andere sympathicomimetische Amine. Biosynthese und Inaktivierung, Freisetzung und Wirkung. Ergebn. Physiol. 58, 1–580 (1966).
Holzbauer, M., Vogt, M.: Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J. Neurochem. 1, 8–11 (1956).
Johnston, J.P.: Some observations upon a new inhibitor of monoamine oxidase. Biochem. Pharmacol. 17, 1285–1297 (1968).
Kapeller-Adler, R.: Amine oxidases and methods for their study. New York, London, Sydney, Toronto: John Wiley & Sons 1970.
Kim, H.C., D’iorio, A.: Possible isoenzymes of monoamine oxidase in rat tissues. Canad. J. Biochem. 46, 295–297 (1968).
Kopin, I. J.: The influence of false adrenergic transmitters on adrenergic neurotransmission. In: Adrenergic Neurotransmission, pp. 95–104. Ciba Foundation Study Group No. 33. Ed. by G.E.W. Wolstenholme and Maeve O’connor. London: Churchill 1968.
Langemann, H.: Enzymes and their substrates in the adrenal gland of the ox. Brit. J. Pharmacol. 6, 318–324 (1951).
Levi-Montalcini, R., Angeletti, P. V.: Nerve growth factor. Physiol. Rev. 48, 534–569 (1968).
Loewi, O.: Über humorale Übertragbarkeit der Herznervenwirkung. I. Mitteilung. Pflügers Arch. ges. Physiol. 189, 239–242 (1921).
Loewi, O.: Über humorale Übertragbarkeit der Herznervenwirkung. Naturwissenschaften 10, 52–55 (1922).
Loewi, O.: Quantitative und qualitative Untersuchung über den Sympathicusstoff. Pflügers Arch, ges. Physiol. 237, 504–514 (1936).
Mayer, S.E.: Adenyl cyclase as a component of the adrenergic receptor. In: Ciba Foundation Symposium on Molecular Properties of Drug Receptors, pp. 43–58. Ed. by Ruth Porter and Maeve O’connor. London: Churchill 1970.
Mcewen, C.M.: Human plasma monoamine oxidase. I. Purification and identification. J. biol. Chem. 240, 2003–2010 (1965).
Melville, K. I.: The antisympathomimetic action of dioxane compounds (F883 and F933), with specific reference to the vascular responses to dihydroxyphenylethanolamine (Arterenol) and nerve stimulation. J. Pharmacol, exp. Ther. 59, 317–327 (1937).
Montagu, K. R.: Catechol compounds in rat tissues and in brains of different animals. Nature (Lond.) 180, 244–245 (1957).
Nagatsu, T., Levitt, M., Udenfriend, S.: Tyrosine hydroxylase. The initial step in nor-epinephrine biosynthesis. J. biol. Chem. 239, 2910–2917 (1964).
Nickerson, M.: Nonequilibrium drug antagonism. Pharmacol. Rev. 9, 246–259 (1957).
Nickerson, M., Goodman, L.S.: Pharmacological properties of a new adrenergic blocking agent: N,N-dibenzyl-β-chloroethylamine (Dibenamine). J. Pharmacol, exp. Ther. 89, 167–185 (1947).
Øye, I., Sutherland, E.W.: The effect of epinephrine and other agents on adenyl cyclase in the cell membrane of avian erythrocytes. Biochim. biophys. Acta (Amst.) 127, 347–354 (1966).
Partridge, S.M.: Biosynthesis and nature of elastin structures. Fed. Proc. 25, 1023–1029 (1966).
Peart, W.S.: The nature of splenic sympathin. J. Physiol. (Lond.) 108, 491–501 (1949).
Pichler, H., Suko, J., Hertting, G.: Action of drugs upon the formation of tritiated water from dl-7-H3-noradrenaline in the rat. Biochem. Pharmacol. 17, 1329–1337 (1968).
Pletscher, A., Shore, P.A., BRODIE, B.: Serotonin release as a possible mechanism of reserpine action. Science 122, 374–375 (1955).
Quastel, J.H.: Amine Oxidases. In: Handbook of Neurochemistry. Ed. by A. Lajtha. Vol. IV, pp. 285–312. New York-London: Plenum Press 1970.
Racker, E., Proctor, H.: Reconstitution of the outer mitochondrial membrane with monoamine oxidase. Biochem. biophys. Res. Commun. 39, 1120–1125 (1970).
Robison, G.A., Butcher, R.W., Sutherland, E.W.: Adenyl cyclase as an adrenergic receptor. Ann. N.Y. Acad. Sci. 139, 703–723 (1967).
Schnaitman, C., Erwin, V.G., Greenawalt, J.W.: The submitochondrial localization of monoamine oxidase. J. Cell Biol. 32, 719–735 (1967).
Schümann, H.J.: Nachweis von Oxytyramin (Dopamin) in sympathischen Nerven und Ganglien. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 227, 566–573 (1956).
Sjoerdsma, A.: Catecholamine-drug interaction in man. Pharmacol. Rev. 18, 673–683 (1966).
Sourkes, T., Heneague, P., Trano, Y.: Enzymatic decarboxylation of isomers and derivatives of dihydroxyphenylalanine. Arch. Biochem. Biophys. 40, 185–193 (1952).
Stehle, R.L., Ellsworth, H.C.: Dihydroxyphenylethanolamine (Arterenol) as a possible sympathetic hormone. J. Pharmacol, exp. Ther. 59, 114–121 (1937).
Suko, J., Linet, O., Hertting, G.: Tritiumwasser in Speicheldrüsen, im Speichel und Plasma der Katze nach Injektion von DL–7-H3-Noradrenalin. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 256, 439–449 (1967).
Sutherland E. W., Cori C. F.: Effect of hyperglycemic factor and epinephrine on liver Phosphorylase. J. biol. Chem. 188, 531–543 (1951).
Sutherland E. W., Cori C. F., Rall, T.W.: The relation of adenosine-3’,5’-phosphate and phosphorylase to the actions of catecholamines and other hormones. Pharmacol. Rev. 12, 265–299 (1960 a).
Sutherland E. W., Cori C. F., Rall, T.W.: The relation of adenosine–3’,5’-phosphate to the action of catecholamines. In: Ciba Foundation Symposium on Adrenergic Mechanisms, pp. 295–304. Ed. by J.R. Vane, G.E.W. Wolstenholme and Maeve O’connor. London: Churchill 1960b.
Tipton, K.F.: The presence of flavine-adenine dinucleotide in preparations of pig-brain mitochondria. Biochem. J. 104, 36P–37P (1967).
Tipton, K.F.: The prosthetic groups of pig brain mitochondrial monoamine oxidase. Biochim. biophys. Acta (Amst.) 159, 451–459 (1968).
Trendelenburg, P.: Adrenalin und adrenalinverwandte Substanzen. In: Handbuch der experimentellen Pharmakologie, pp. 1130–1293. Ed. by A. Heffter. Berlin: Julius Springer 1924.
Trendelenburg, P.: Die Hormone. Ihre Physiologie und Pharmakologie. Erster Band. Berlin: Julius Springer 1929.
Udenfriend, S., Wyngaarden, J.B.: Precursors of adrenal epinephrine and norepinephrine in vivo. Biochim. biophys. Acta (Amst.) 20, 48–52 (1956).
Vogt, M.: The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J. Physiol. (Lond.) 123, 451–481 (1954).
Weil-Malherbe, H., Bone, A.D.: Intracellular distribution of catecholamines in the brain. Nature (Lond.) 180, 1050–1051 (1957).
Yamada, H., Yasunobu, K.T.: Monoamine oxidase. I. Purification, crystallization and properties of plasma monoamine oxidase. J. biol. Chem. 237, 1511–1516 (1962).
Youdim, M.B.H., Sandler, M.: Isoenzymes of soluble monoamine oxidase from human placental and rat-liver mitochondria. Biochem. J. 105, 43 P (1967).
Zeller, E.A., Barsky, J., Berman, E.R., Fouts, J.R.: Action of isonicotinic acid hydrazide and related compounds on enzymes of brain and other tissues. J. Lab. clin. Med. 40, 965–966 (1952).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Blaschko, H. (1972). Introduction Catecholamines 1922–1971. In: Blaschko, H., Muscholl, E. (eds) Catecholamines. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65249-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-65249-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65251-6
Online ISBN: 978-3-642-65249-3
eBook Packages: Springer Book Archive